Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-8-14
|
pubmed:abstractText |
Omeprazole, a widely used and potent gastric proton pump inhibitor, induces cytochrome P450 (CYP) 1A2 in humans. Induction is most pronounced in slow metabolizers of S-mephenytoin because CYP2C19 (S-mephenytoin hydroxylase) is responsible for the elimination of omeprazole. Acetaminophen (INN, paracetamol), a widely used and effective analgesic and antipyretic agent, causes serious hepatic and renal toxicity at high doses by conversion of acetaminophen to the toxic intermediate N-acetyl-p-benzoquinone imine (NAPQI) through CYP1A2, CYP2E1, and CYP3A4. This study evaluated whether omeprazole pretreatment in five rapid and five slow metabolizers of S-mephenytoin could increase thioether (an estimate of NAPQI production) metabolite formation from acetaminophen. The results of this study show that, despite induction of CYP1A2 activity in slow metabolizers (a 75% increase in plasma clearance of caffeine), the formation of NAPQI from acetaminophen was not increased after 7 days of omeprazole administration (40 mg/day). This suggests that induction of CYP1A2 activity by omeprazole is unlikely to increase the risk of acetaminophen hepatotoxicity.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetaminophen,
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Non-Narcotic,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Mephenytoin,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0009-9236
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
21-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9246016-Acetaminophen,
pubmed-meshheading:9246016-Adult,
pubmed-meshheading:9246016-Analgesics, Non-Narcotic,
pubmed-meshheading:9246016-Anti-Ulcer Agents,
pubmed-meshheading:9246016-Anticonvulsants,
pubmed-meshheading:9246016-Female,
pubmed-meshheading:9246016-Humans,
pubmed-meshheading:9246016-Male,
pubmed-meshheading:9246016-Mephenytoin,
pubmed-meshheading:9246016-Middle Aged,
pubmed-meshheading:9246016-Omeprazole,
pubmed-meshheading:9246016-Phenotype,
pubmed-meshheading:9246016-Reference Values
|
pubmed:year |
1997
|
pubmed:articleTitle |
The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin.
|
pubmed:affiliation |
Department of Pharmacology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|